Saint Gely du Fesc, France

Pierre Roux

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 51(Granted Patents)


Location History:

  • Saint Gely du Fese, FR (2013)
  • Saint Gely du Fresc, FR (2020)
  • Saint-Gely-du Fesc, FR (2011 - 2022)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
17 patents (USPTO):

Title: The Innovations of Pierre Roux in Cancer Research

Introduction

Pierre Roux, an inventive force hailing from Saint Gely du Fesc, France, has made significant contributions to the field of oncology with a focus on cancer stem cells. With a remarkable total of 17 patents to his name, Roux is driving innovation in cancer treatment methodologies.

Latest Patents

Among his latest patents, the inventions titled "Delta133P53Beta and Delta133P53Gamma isoforms are biomarkers of cancer stem cells" stand out. This innovative work deals with a method for producing cancer stem cells through the overexpression of specific isoforms, namely Δ133p53β and Δ133p53γ. Additionally, it outlines a method for predicting the risk of inducing cancer stem cells through chemotherapy based on the detection of increases in these isoforms. His research also explores therapeutic combinations involving chemotherapeutic agents and agents that reduce the expression of these isoforms. Furthermore, he has developed compounds for treating cancer that include complex structural formulas meant to enhance efficacy and minimize side effects.

Career Highlights

Throughout his career, Roux has held key positions in prestigious research institutions such as the Centre National de la Recherche Scientifique and the Institut Curie. His work has not only garnered numerous patents but has also positioned him as a leading expert in cancer stem cell research, paving new avenues for treatment options and therapeutic strategies.

Collaborations

In his journey, Roux has collaborated with notable colleagues, including Jamal Tazi and Florence Mahuteau. These collaborations have been instrumental in advancing his research and innovations in the oncological field, resulting in groundbreaking discoveries that benefit cancer patients.

Conclusion

Pierre Roux exemplifies the spirit of innovation in medical research. His extensive patent portfolio and collaborative efforts underscore his dedication to improving cancer treatment. As research continues to evolve, Roux's contributions will undoubtedly hold lasting significance in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…